Effect of Helicobacter pylori eradication on blood ammonia levels in cirrhotic patients: A systematic review

Hepato-Gastroenterology

Volumn 59, Issue 120, 2012, Pages 2576-2581

  Qin, Shan Yu ^a   Jiang, Hai Xing ^a   Ning, Hong Jian ^a   Nie, Hai Ming ^a   Tao, Lin ^a   Hu, Bang Li ^b   Guo, Xiao Yun ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b Guangxi Information Institute   (China)

Author keywords

Ammonia; Blood; Eradication; Helicobacter pylori; Meta analysis

Indexed keywords

AMMONIA; ANTIBIOTIC AGENT;

AMMONIA BLOOD LEVEL; ARTICLE; ASIAN; CAUCASIAN; CHILD PUGH SCORE; CLINICAL EFFECTIVENESS; DRUG EFFECT; DRUG EFFICACY; ERADICATION THERAPY; ETHNIC DIFFERENCE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LIVER CIRRHOSIS; LIVER DYSFUNCTION; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

AMMONIA; ANTI-BACTERIAL AGENTS; BIAS (EPIDEMIOLOGY); BIOLOGICAL MARKERS; DOWN-REGULATION; EVIDENCE-BASED MEDICINE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LIVER CIRRHOSIS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84872079825     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12270     Document Type: Article

References (34)

1. LeVeen HH, LeVeen EG, LeVeen RF: Awakenings to the pathogenicity of urease and the requirement for continuous long term therapy. Biomed Pharmacother 1994; 48:157-166.
2. Owen RJ: Bacteriology of Helicobacter pylori. Baillieres Clin Gastroenterol 1995; 9:415-446.
3. Gubbins GP, Moritz TE, Marsano LS, et al.: Helicobacter pylori is a risk factor for hepatic encephalopathy in acute alcoholic hepatitis: the ammonia hypothesis revisited. The veterans administration cooperative study group No. 275. Am J Gastroenterol 1993; 88:1906-1910.
4. Demirturk L, Yazgan Y, Zci O, et al.: The effect of Helicobacter pylori eradication on gastric juice and blood ammonia concentrations and on visual evoked potentials in cirrhotics. Helicobacter 2001; 6:325-330.
5. Nandakumar R, Naik AS, Pandit B, Kamat R, Bhatia SJ: Effect of Helicobacter pylori eradication on serum ammonia levels in patients with chronic liver disease. Indian J Gastroenterol 2003; 22:221-223.
6. Queiroz DM, Rocha AM, Rocha GA, et al.: Association between Helicobacter pylori infection and cirrhosis in patients with chronic hepatitis C virus. Dig Dis Sci 2006; 51:370-373.
7. Zullo A, Hassan C, Morini S: Helicobacter pylori infection in patients with liver cirrhosis: facts and fictions. Dig Liver Dis 2003; 35:197-205.
8. Udayakumar N, Subramaniam K, Umashankar L, Verghese J, Jayanthi V: Predictors of mortality in hepatic encephalopathy in acute and chronic liver disease: a preliminary observation. J Clin Gastroenterol 2007; 41:922-926.
9. Hong L, Zhao Y, Han Y, et al.: Reversal of migraine symptoms by Helicobacter pylori eradication therapy in patients with hepatitis-B-related liver cirrhosis. Helicobacter 2007; 12:306-308.
10. Chakrabarti P, Zullo A, Hassan C, et al.: Helicobacter pylori, gastric juice, and arterial ammonia levels in patients with cirrhosis. J Clin Gastroenterol 2002; 34:578-581.
11. Ito S, Miyaji H, Azuma T, et al.: Hyperammonaemia and Helicobacter pylori. Lancet 1995; 346:124-125.
12. Miyaji H, Ito S, Azuma T, et al.: Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis. Gut 1997; 40:726-730.
13. Miquel J, Barcena R, Boixeda D, et al.: Role of Helicobacter pylori infection and its eradication in patients with subclinical hepatic encephalopathy. Eur J Gastroenterol Hepatol 2001; 13:1067-1072.
14. Zullo A, Rinaldi V, Meddi P, Hassan C, Winn S, Attili AF: Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients. Am J Gastroenterol 1999; 94:2214-2218.
15. Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-634.
16. Group CEPaOoC: EPOC resources for review authors. Accessed at http://epoc.cochrane.org/epoc-resources-review-authors on 5 July 2011.
17. Higgins JPT, Green S, eds: Cochrane handbook for systematic reviews of interventions 4.2.6. In: The Cochrane Library, Issue 4. Chichester, United Kingdom: John Wiley & Sons Ltd, 2006.
18. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188.
19. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21:1539-1558.
20. Thompson SG, Higgins JP: How should meta-regression analyses be undertaken and interpreted? Stat Med 2002; 21:1559-1573.
21. Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50:1088-1101.
22. Agrawal A, Gupta A, Chandra M, Koowar S: Role of Helicobacter pylori infection in the pathogenesis of minimal hepatic encephalopathy and effect of its eradication. Indian J Gastroenterol 2011; 30:29-32.
23. Abdel-Hady H, Zaki A, Badra G, et al.: Helicobacter pylori infection in hepatic encephalopathy: Relationship to plasma endotoxins and blood ammonia. Hepatol Res 2007; 37:1026-1033.
24. Vasconez C, Elizalde JI, Llach J, et al.: Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication. J Hepatol 1999; 30:260-264.
25. Yang CS, Cao SY, He XJ, Wang YX, Zhang YL: Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2007; 19:422-424.
26. Chen SJ, Wang LJ, Zhu Q, Cai JT, Chen T, Si JM: Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients. World J Gastroenterol 2008; 14:1914-1918.
27. Mousseau DD, Butterworth RF: Current theories on the pathogenesis of hepatic encephalopathy. Proc Soc Exp Biol Med 1994; 206:329-344.
28. Dasani BM, Sigal SH, Lieber CS: Analysis of risk factors for chronic hepatic encephalopathy: the role of Helicobacter pylori infection. Am J Gastroenterol 1998; 93:726-731.
29. DuBois S, Eng S, Bhattacharya R, et al.: Breath ammonia testing for diagnosis of hepatic encephalopathy. Dig Dis Sci 2005; 50:1780-1784.
30. Huber M, Rossle M, Siegerstetter V, et al.: Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis. Hepato-gastroenterol 2001;48:541-544.
31. Calvet X, Nogueras C, Roque M, Sanfeliu I: Helicobacter pylori is not a risk factor for hepatic encephalopathy. Dig Liver Dis 2001; 33:414-419.
32. Quero JC, Hartmann IJ, de Rooij F, Wilson JH, Schalm SW: Hyperammonaemia and Helicobacter pylori. Lancet 1995; 346:713-714.
33. Nardone G, Coscione P, D'Armiento FP, et al.: Cirrhosis negatively affects the efficiency of serologic diagnosis of Helicobacter pylori infection. Ital J Gastroenterol 1996; 28:332-336.
34. Taylor-Robinson SD, Jackson N, Buckley C: Helicobacter pylori, ammonia and the brain. Gut 1997; 40:805-806.